Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHPA chimes in on OTC dosing device guidance

This article was originally published in The Tan Sheet

Executive Summary

FDA's guidance on dosage delivery devices for liquid OTCs should adopt some measures from the Consumer Healthcare Products Association's voluntary industry guidelines on the subject, the trade group says. Among the recommendations in a Feb. 2 1letter, FDA should make milliliter the preferred primary unit of liquid measure, as CHPA says its member companies did. This echoes a change suggested by the Institute for Safe Medication Practices in a recent comment to the agency (2"The Tan Sheet" Feb. 1, 2010). CHPA also encourages FDA to limit spoon measures to either "teaspoonful" or "tablespoonful" to reduce confusion, and to tell firms to limit text on a dosing device that "risks obscuring important liquid measure markings." CHPA added dosing device language to its voluntary guidelines in November 2009 (3"The Tan Sheet" Dec. 7, 2009)
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS103768

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel